Lake Street Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $235

Benzinga Newsdesk www.benzinga.com Neutral 49.8%

Neg 0% Neu 49.8% Pos 0%

Lake Street analyst Ben Haynor initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $235.